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Graphical abstract
Summary of Cryptosporidium transmission, infection and putative virulence factors.
The transmission pathway in blue maps the routes oocysts might take from source to vulnerable host. The infection pathway in 
red shows putative virulence factors - enzymes and genes or gene families,
Abstract
The protozoan Cryptosporidium is notorious for its resistance to chlorine disinfection, a mainstay of water treatment. Human 
infections, mainly of the small intestine, arise from consumption of faecally contaminated food or water, environmental 
exposure, and person-to-person or animal-to-person spread. Acute gastrointestinal symptoms can be prolonged but are 
usually self-limiting. Problems arise with immune-deficient, including malnourished, people including chronic diarrhoea, 
hepato-biliary tree and extra-gastrointestinal site infection, and few options for treatment or prevention exist. Although genom-
ics has enabled refined classification, identification of chemotherapeutic targets and vaccine candidates, and putative factors 
for host adaption and pathogenesis, their confirmation has been hampered by a lack of biological tools.
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TaxOnOMy
A proposed revised taxonomy is given in parentheses. 
Domain Eukarya, phylum Apicomplexa, class Sporozoasida 
(Gregarinomorphea), order Eucoccidiorida (Cryptogregarida), 
family Cryptosporidiidae, genus Cryptosporidium, species 
C. parvum, C. hominis and at least 35 others. Confirmation of 
laboratory reports of free-living stages would strengthen the 
gregarine affinity.
PROPERTIEs
Cryptosporidium is traditionally considered an obligate gastro-
intestinal parasite, but free-living stages have been reported 
in laboratory conditions. Metabolic pathways are minimal as 
most nutrients are scavenged from the host; energy produc-
tion is mainly by glycolysis. The life cycle comprises asexual 
and sexual phases, sequentially in the same host, culminating 
in oocysts shed in faeces. Each oocyst contains four infective 
sporozoites and can survive for months in moist, ambient 
conditions and resists chlorine disinfection enabling food 
and waterborne transmission. Many species infect humans 
but C. parvum (zoonotic) and C. hominis (anthroponotic) 
are most prevalent. Virulence and pathogenicity factors are 
poorly described.
GEnOME
Next generation sequencing was used to re-sequence and 
re-annotate the 2004 C. hominis TU502 genome, annotate 
a new reference genome (UdeA01) prepared from oocysts 
without animal propagation, and re-annotate the original 
C. parvum Iowa II genome. The resulting C. hominis UdeA01 
and C. parvum genomes are, respectively, 9.05 and 9.10 Mbp 
in length, comprising highly compact coding genes (3819 and 
3941; 75.4 and 75.7 %), AT-rich (GC content both 32 mol%), 
with introns in 10.9 and 10.8 % of genes arranged on eight 
chromosomes (range 0.88–1.34 Mbp). Sequence similarity is 
97 % and synteny is high; 11 protein-coding sequences were 
identified in C. hominis and five in C. parvum. Phenotypic 
differences are potentially due to more subtle sequence 
divergence (SNPs and indels) and gene expression. Genome 
evolution was largely reductive and Cryptosporidium depends 
mainly on host cells for basic nutrients.
High-quality genome sequences are increasingly available, 
analysable via http:// cryptodb. org/ cryptodb/, including 
other C. hominis genomes, human-adapted C. parvum, other 
zoonotic species including C. meleagridis, and host-adapted 
species rarely found in humans (C. muris, C. andersoni, 
C. baileyi and C. tyzzeri). Comparative genomics has iden-
tified several putative virulence factors, mainly in hyper-
polymorphic subtelomeric regions, that require biological 
confirmation.
PhyLOGEny
Historically, Cryptosporidium species were described on the 
basis of host, infection site and oocyst morphology. Mitosome 
metabolism and invasion-related proteins differ between 
gastric and intestinal species; gastric C. muris and C. ander-
soni retain all enzymes associated with the TCA cycle and a 
conventional respiratory chain system .
Human infections were identified originally as C. parvum but 
delineated in the 1990s as genotype 1 or H (human-adapted) 
and genotype 2 or C (cattle/broad host range). Molecular 
characterization led to re-descriptions and novel species; in 
2002 genotype 1 was described as C. hominis. Most human 
pathogens (C. parvum, C. cuniculus and C. meleagridis) form 
a clade with C. hominis. A human-adapted C. parvum lineage 
has been described [1].
It is likely that ‘isolates’ comprise a population of intraspecies 
variants arising from sexual recombination. Discriminatory 
analysis using multi-locus genotyping is required. Single-cell 
whole genome sequencing has been demonstrated using flow 
cytometry to separate individual oocysts.
KEy FEaTuREs and dIsCOvERIEs
In 1976 Cryptosporidium was identified as the cause of two 
cases of human gastroenteritis, and veterinary importance 
in ruminants was recognized, following histological exami-
nation. The organism rose to prominence with the AIDS 
epidemic in the 1980s. These patients were susceptible to 
severe, intractable and sometimes fatal cryptosporidiosis. 
Recognition of the impact in the general population followed 
large drinking water outbreaks, highlighting that supplies 
compliant with World Health Organization quality standards 
(based on Escherichia coli) could present a risk of crypto-
sporidiosis. Human infectivity studies and dose–response 
modelling confirmed the significance of small numbers of 
oocysts in drinking water; single oocyst infection prob-
abilities could be as high as 72 % [2]. Chlorine resistance 
necessitates alternative water treatment, chiefly filtration and 
secondary disinfection using UV light or ozone. Introduction 
of European guidelines on water quality, promoting improved 
source water protection, appears to have been effective to 
some extent in reducing the numbers of water-borne cases 
and outbreaks. Transmission via food and recreational waters 
are of concern.
Highly active antiretroviral therapy has reduced the preva-
lence of life-threatening cryptosporidiosis in people positive 
for human immunodeficiency virus (HIV), but individuals 
with other causes of severe T-cell depletion, including primary 
immunodeficiency or haematopoietic stem-cell transplanta-
tion, remain at risk of severe cryptosporidiosis, characterized 
by biliary involvement, sclerosing cholangitis and, rarely, liver 
cirrhosis.
In immune-competent people, post-infectious sequelae not 
dissimilar to those following bacterial gastroenteritis are 
described. Furthermore, the importance of Cryptosporidium 
in childhood in low-income countries is increasingly recog-
nized. The Global Enteric Multicentre Study identified Crypto-
sporidium among the four most common infectious causes of 
moderate-to-severe diarrhoea in children aged <24 months 
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in sub-Saharan Africa and India/Pakistan/Bangladesh/Nepal/
Afghanistan, and generated estimates of 2.9 and 4.7 million 
Cryptosporidium-attributable cases respectively annually in 
that age group, with ~202 000 total Cryptosporidium-attrib-
utable deaths [3]. Growth stunting and malnutrition can arise 
in young children, leading to an impaired immune response 
and chronic infection.
Only nitazoxanide has been shown to be an effective treatment 
for cryptosporidiosis in a randomized placebo-controlled 
trial and is licensed by the US Food and Drug Administration 
(FDA) for immunocompetent cryptosporidiosis patients aged 
>1 year; there is no European licence. In clinical practice, 
reducing levels of immunosuppression, where possible, is 
frequently helpful in controlling severe infection.
Study of Cryptosporidium biology and virulence was until 
recently complicated by an inability to produce oocysts and 
achieve prolonged culture in vitro. A successful application 
of CRISPR-Cas9 technology to the organism and develop-
ments in continuous culture in vitro show promise for new 
approaches in research [4, 5].
OPEn QuEsTIOns
(1) To what extent and by what mechanisms does Crypto-
sporidium contribute to sub-clinical environmental 
enteropathy in low-resource settings? Understanding the 
role of Cryptosporidium in the cycle of mucosal damage, 
inflammation and malnutrition following recurrent gas-
trointestinal infections will help to focus improvements 
for survival and long-term developmental potential.
(2) Which aspects might explain the variable host-specificity 
or adaption of Cryptosporidium species? Host-related 
features such as the differing gastrointestinal conditions 
(e.g. pH and body temperature) between and among 
vertebrates known to be infected by at least one Crypto-
sporidium species might be involved. Host–parasite 
interactions may differ, for example in the cell-surface 
molecules involved in host-cell binding and/or invasion. 
Importantly, the composition and pathological roles of 
other microbes (mirobiota) in the host gut are only just 
beginning to be investigated.
(3) Further understanding of the differing innate and 
acquired immunological responses of the host against 
Cryptosporidium is needed. Understanding of whether 
(and how) these factors influence the susceptible host 
range of Cryptosporidium species will be of critical 
importance in the effective control of cryptosporidiosis.
(4) What parasite-related factors influence the clinical 
impact of infection? These factors are not well under-
stood, and neither is the importance of the population 
structure of Cryptosporidium species during infection. 
Deep sampling of host and parasite populations in 
defined geographical areas needs to be undertaken.
(5) If laboratory reports of a free-living stage were to be 
confirmed independently, is there any public health 
significance? Cryptosporidium control in drinking 
water is currently based on prevention and removal of 
oocyst contamination, but if free-living stages were to 
be confirmed and shown to enable proliferation outside 
of laboratory conditions, for example in environmental 
biofilms, a new dimension of control measures would 
need to be implemented.
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